Zobrazeno 1 - 10
of 243
pro vyhledávání: '"Shashank Joshi"'
Autor:
Paramesh Shamanna, Ravi Sankar Erukulapati, Ashutosh Shukla, Lisa Shah, Bree Willis, Mohamed Thajudeen, Rajiv Kovil, Rahul Baxi, Mohsin Wali, Suresh Damodharan, Shashank Joshi
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract This retrospective observational study, building on prior research that demonstrated the efficacy of the Digital Twin (DT) Precision Treatment Program over shorter follow-up periods, aimed to examine glycemic control and reduced anti-d
Externí odkaz:
https://doaj.org/article/7f68e7cc279f4a7ab691a158ac1f3c85
Autor:
Paramesh Shamanna, Shashank Joshi, Mohamed Thajudeen, Lisa Shah, Terrence Poon, Maluk Mohamed, Jahangir Mohammed
Publikováno v:
Frontiers in Endocrinology, Vol 15 (2024)
BackgroundType 2 Diabetes (T2D) is a complex condition marked by insulin resistance and beta-cell dysfunction. Traditional dietary interventions, such as low-calorie or low-carbohydrate diets, typically overlook individual variability in postprandial
Externí odkaz:
https://doaj.org/article/41332d74e1274435899e411e41efa12e
Autor:
Ashok K. Das, Sanjay Kalra, Shashank Joshi, Ambrish Mithal, K. M. Prasanna Kumar, A. G. Unnikrishnan, Hemant Thacker, Bipin Sethi, Subhankar Chowdhury, Amarnath Sugumaran, Ashwini Satpathy, Arvind Gadekar, Shalini K. Menon, Renuka Neogi, Deepa Chodankar, Chirag Trivedi, S. K. Wangnoo, A. H. Zargar, Nadeem Rais, LANDMARC study group
Publikováno v:
Endocrinology, Diabetes & Metabolism, Vol 6, Iss 5, Pp n/a-n/a (2023)
Abstract Introduction LANDMARC (CTRI/2017/05/008452), a prospective, observational real‐world study, evaluated the occurrence of diabetes complications, glycemic control and treatment patterns in people with type 2 diabetes mellitus (T2DM) from pan
Externí odkaz:
https://doaj.org/article/57997eb5dcc94d18a610e0249ced28fc
Autor:
Shambo Samrat Samajdar, Shatavisa Mukherjee, Saibal Moitra, Jyotirmoy Pal, Shashank Joshi, Santanu Kumar Tripathi
Publikováno v:
Lung India, Vol 40, Iss 2, Pp 107-111 (2023)
Background: Cough is a wearisome and exasperating symptom affecting the daily life of the infected patient. Cough due to coronavirus disease 2019 (COVID-19) causes excessive morbidity in human populations globally. Apart from the morbidity associated
Externí odkaz:
https://doaj.org/article/5899172eee5a472cb1108c67780ed885
Autor:
Amit Gupta, Banshi Saboo, Jothydev Kesavadev, Manoj Chawla, Rakesh Parikh, Mithun Bhartia, Shashank Joshi, Sanjay Kalra, A G Unnikrishnan, Anuj Maheshwari, Sanjay Agarwal, Brij Makkar, Purvi Chawla, Jayant Panda, Tanvir Kaur, Ashok Kumar Das, Viswanthan Mohan
Publikováno v:
Journal of Diabetology, Vol 14, Iss 4, Pp 183-185 (2023)
Externí odkaz:
https://doaj.org/article/12603450868e4f0ea874a90382e46af1
Autor:
Ashok K. Das, Sanjay Kalra, Shashank Joshi, Ambrish Mithal, Prasanna Kumar K. M., Ambika G. Unnikrishnan, Hemant Thacker, Bipin Sethi, Subhankar Chowdhury, Amarnath Sugumaran, Senthilnathan Mohanasundaram, Shalini K. Menon, Vaibhav Salvi, Deepa Chodankar, Saket Thaker, Chirag Trivedi, Subhash K. Wangnoo, Abdul H. Zargar, Nadeem Rais
Publikováno v:
Endocrinology, Diabetes & Metabolism, Vol 6, Iss 2, Pp n/a-n/a (2023)
Abstract Introduction There are limited data on the real‐world management of diabetes in the Indian population. In this 2‐year analysis of the LANDMARC study, the management of type 2 diabetes mellitus (T2DM) and related complications were assess
Externí odkaz:
https://doaj.org/article/13fda9e1f0fd4e0794cc2f760259f3eb
Autor:
Shambo Samrat Samajdar, Shatavisa Mukherjee, Santanu Kumar Tripathi, Jyotirmoy Pal, Shashank Joshi
Publikováno v:
Journal of Clinical and Diagnostic Research, Vol 17, Iss 1, Pp OC22-OC25 (2023)
Introduction: Fixed-dose combination containing triple antihypertensive agents (Angiotensin-Converting Enzyme Inhibitor (ACE-I)/Angiotensin Receptor Blocker (ARB), diuretic and Calcium Channel Blocker (CCB)) is recommended to achieve target Blood-Pre
Externí odkaz:
https://doaj.org/article/1bdbedd0bb15433f900a7e9f51029ac4
Autor:
Paramesh Shamanna, Shashank Joshi, Lisa Shah, Mala Dharmalingam, Banshi Saboo, Jahangir Mohammed, Maluk Mohamed, Terrence Poon, Nathan Kleinman, Mohamed Thajudeen, Ashok Keshavamurthy
Publikováno v:
Clinical Diabetes and Endocrinology, Vol 7, Iss 1, Pp 1-8 (2021)
Abstract Background Type 2 diabetes reversal has been viewed in the literature primarily as a dichotomous event (reversed or not reversed), even though this viewpoint may not be optimal for clinicians or patients. This cohort study’s objectives wer
Externí odkaz:
https://doaj.org/article/b498885d7d104b639d841041d88afbd9
Autor:
Shashi Bhushan B L, Sunil Wanve, Parshottam Koradia, Vinay Bhomia, Pravin Soni, Sisir Chakraborty, Akash Khobragade, Shashank Joshi, Sanjeev Kumar Mendiratta, Kevin Kumar Kansagra, Anurag Parihar, Sunil Sharma, Jatin Patel
Publikováno v:
International Journal of Infectious Diseases, Vol 111, Iss , Pp 281-287 (2021)
Objective: To evaluate the efficacy and safety of pegylated interferon alpha-2b (PEG IFN-α2b) administered in conjunction with the standard of care (SOC) in subjects with moderate coronavirus disease-19 (COVID-19). Methods: In this study, adult subj
Externí odkaz:
https://doaj.org/article/4224fcf9b36b4c10afc34d1cc3b29bf7
Autor:
Shambo Samrat Samajdar, Shatavisa Mukherjee, Saibal Moitra, Jyotirmoy Pal, Shashank Joshi, Santanu Kumar Tripathi
Publikováno v:
Lung India, Vol 40, Iss 5, Pp 484-485 (2023)
Externí odkaz:
https://doaj.org/article/e73b6b8c5c354fd6a56433d1fb18f0a7